Rethinking research ethics: The case of postmarketing trials

Science

Volumn 336, Issue 6081, 2012, Pages 544-545

  London, Alex John ^a   Kimmelman, Jonathan ^b   Carlisle, Benjamin ^b  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; ETHICS; HUMAN GEOGRAPHY; MARKETING; MEDICINE; POLICY MAKING; RESEARCH WORK;

CANADA; CLINICAL RESEARCH; DRUG INDUSTRY; DRUG SAFETY; HEALTH CARE QUALITY; HUMAN; MEDICAL INFORMATION; PEER REVIEW; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RESEARCH ETHICS; SHORT SURVEY; UNITED KINGDOM; UNITED STATES; ARTICLE; ETHICS; INFORMED CONSENT; LEGAL ASPECT; MARKETING; PHASE 4 CLINICAL TRIAL (TOPIC); POLICY; PROFESSIONAL STANDARD; RESEARCH SUBJECT; STANDARD;

CANADA; UNITED KINGDOM; UNITED STATES;

CLINICAL TRIALS, PHASE IV AS TOPIC; DRUG INDUSTRY; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMANS; INFORMED CONSENT; MARKETING; PUBLIC POLICY; RESEARCH SUBJECTS; UNITED STATES;

EID: 84860445985     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1216086     Document Type: Short Survey

References (18)

1. U.S. Department of Health and Human Services, Fed. Regist. 76, 44512 (2011).
2. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (CIHR, NSERC, SSHRC, Ottawa, 2010).
3. U.K. Department of Health, Research Governance Framework for Health and Social Care (HMSO, London, ed. 2, 2005).
4. Patient Protection and Affordable Care Act. Public Law 111-148 (2010).
5. D. Carpenter, Reputation and Power (Princeton Univ. Press, Princeton, NJ, 2010).
6. H. C. Sox, D. Rennie, Ann. Intern. Med. 149, 279 (2008).
7. B. M. Psaty, D. Rennie, JAMA 295, 2787 (2006).
8. M. A. Steinman, L. A. Bero, M. M. Chren, C. S. Landefeld, Ann. Intern. Med. 145, 284 (2006).
9. B. M. Psaty, C. D. Furberg, W. A. Ray, N. S. Weiss, JAMA 292, 2622 (2004).
10. S. E. Nissen, Eur. Heart J. 31, 773 (2010).
11. J. Hasford, T. Lamprecht, Eur. J. Clin. Pharmacol. 53, 369 (1998).
12. C. Elliott, Mother Jones 2010 (September-October), 55 (2010).
13. J. N. Rao, L. J. Cassia, BMJ 325, 36 (2002).
14. A. J. London, J. Kimmelman, M. E. Emborg, Science 328, 829 (2010).
15. D. Carpenter, Health Aff. W5, 469 (2005).
16. B. P. Falit, Seton Hall Law Rev. 37, 969 (2007).
17. D. A. Zarin, T. Tse, Science 319, 1340 (2008).
18. M. Teehan, Can. J. Psychiatry 39, 629 (1994).